Literature DB >> 17260002

Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma.

Young-Hyeh Ko1, Sanghui Park, Heekyung Jin, Heesook Woo, Hyunseop Lee, Chaewha Park, Kihyun Kim.   

Abstract

This study aims to investigate the role of granzyme B in the apoptosis of nasal-type NK/T-cell lymphoma. Twenty-four nasal-type NK/T-cell lymphomas were examined by TdT-mediated deoxyuridine triphosphate (dUTP)-biotin nick-end labeling (TUNEL) assay and immunohistochemical staining for active caspase 3, poly(ADP-ribose) polymerase (PARP-1/p85)/p85, and Bcl-2. In addition, HANK-1 and NKL cell lines were analyzed using Western blot analysis. Immunoprecipitation was performed to identify the binding of granzyme B and intrinsic serpin proteinase inhibitor 9 (PI-9). To localize granzyme B, immunogold labeling and immunofluorescence staining were performed. The expression level of granzyme B in tumor tissue was correlated with the apoptosis rate (P=0.015), degree of necrosis (P=0.002), and the levels of active caspase 3 (P=0.036) and poly ADP-ribose polymerase (PARP)-1/p85 (P=0.040). The granzyme B-positive HANK-1 cell line showed increased spontaneous cell death compared to the granzyme B-negative NKL cell line. The untreated HANK-1 cells released cytochrome c into the cytosol with cleavage of caspase 3 and PARP-1. Treatment with granzyme B inhibitor and caspase inhibitor decreased the cleavage of PARP-1. By performing immunogold labeling, granzyme B was identified within the cytolytic granules as well as in the cytosol. Confocal microscopy and immunoprecipitation assays confirmed the colocalization of PI-9 and granzyme B, which formed an SDS-resistant complex. These results suggested that granzyme B leakage induces cell death in NK/T-cell lymphomas via both caspase-dependent and -independent mechanisms, and this leads to the extensive necrosis that is commonly seen in NK/T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17260002     DOI: 10.1038/labinvest.3700517

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

1.  Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity.

Authors:  Debra D Bloom; Sofiya Reshetylo; Cassandra Nytes; Claudia T Goodsett; Peiman Hematti
Journal:  J Immunother       Date:  2018-06       Impact factor: 4.456

2.  Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants.

Authors:  Marshall E Kadin; John Morgan; Haiying Xu; Caroline Glicksman; David Sieber; William P Adams; Pat McGuire; Mark W Clemens; Archana Thakur; Lawrence G Lum
Journal:  Aesthet Surg J       Date:  2021-11-12       Impact factor: 4.283

3.  Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells.

Authors:  Xinguo Jiang; Nicole M Patterson; Yan Ling; Jianwei Xie; William G Helferich; David J Shapiro
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

4.  Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.

Authors:  Thomas D Cunningham; Xinguo Jiang; David J Shapiro
Journal:  Cell Immunol       Date:  2007-05-08       Impact factor: 4.868

5.  Differential PARP cleavage: an indication of heterogeneous forms of cell death and involvement of multiple proteases in the infarct of focal cerebral ischemia in rat.

Authors:  Ganta Vijay Chaitanya; Phanithi Prakash Babu
Journal:  Cell Mol Neurobiol       Date:  2009-02-19       Impact factor: 5.046

6.  Immunohistochemistry of programmed cell death in archival human pathology specimens.

Authors:  Kazuhisa Hasui; Taku Nagai; Jia Wang; Xinshan Jia; Katsuyuki Aozasa; Shuji Izumo; Yoshifumi Kawano; Takuro Kanekura; Yoshito Eizuru; Takami Matsuyama
Journal:  Cells       Date:  2012-05-07       Impact factor: 6.600

7.  Integrated analysis of prognostic immune-related genes in the tumor microenvironment of ovarian cancer.

Authors:  Jing Wang; Xiaoling Su; Chao Wang; Mingjuan Xu
Journal:  Ann Transl Med       Date:  2022-01

8.  Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.

Authors:  Joel D Pearson; Jingxi Zhang; Zuoqiao Wu; Kayla D Thew; Katelynn J Rowe; Julinor T C Bacani; Robert J Ingham
Journal:  Mol Cancer       Date:  2014-08-29       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.